The mechanism of induction of murine macrophage Ia expression by lipopolysaccharide (LPS) was studied. Intraperitoneal injection of 1 jig of LPS resulted in a 3-to 10-fold increase in the number of IA-positive peritoneal macrophages (flow cytometry and immunofluorescence) and a 6-to 16-fold increase by radioimmunoassay. The isolated lipid A moiety of LPS was a potent inducer of macrophage Ia expression. Ia induction required a functional myelopoietic system as indicated by the finding that the response to LPS was eliminated in irradiated (900 rads) mice and reinstated by reconstitution with bone marrow cells. Comparison of LPS-induced Ia expression in normal and LPS-primed mice revealed a faster secondary response to LPS. The memory response could be adoptively transferred to normal mice with nonadherent spleen cells prepared 60 days after LPS injection. Spleen cells prepared 5 days after LPS injection caused Ia induction in LPSnonresponder mice; such induction was not observed in irradiated (900 rads) recipients. The cell responsible for this phenomenon was identified as a Thy-1+, immunoglobulin-negative nonadherent cell. The biosynthesis and expression of Ia were not increased by direct exposure of macrophages to LPS in vitro. Small amounts of LPS inhibited Ia induction by gamma interferon. LPS showed positive regulatory effects on Ia expression by delaying the loss of Ia expression on cultured macrophages and by stimulating the production of Ia-inducing factors. Supernatants from cultured spleen cells stimulated with LPS in vitro contained antiviral and Ia-inducing activity that was acid labile, indicating that the active factor is gamma interferon. We conclude that induction of Ia expression by LPS in vivo is a bone-marrow-dependent, radiation-sensitive process which involves the stimulation of a gamma interferon-producing accessory lymphocyte and a delay in Ia turnover.
The mechanism of induction of murine macrophage Ia expression by lipopolysaccharide (LPS) was studied. Intraperitoneal injection of 1 jig of LPS resulted in a 3-to 10-fold increase in the number of IA-positive peritoneal macrophages (flow cytometry and immunofluorescence) and a 6-to 16 -fold increase by radioimmunoassay. The isolated lipid A moiety of LPS was a potent inducer of macrophage Ia expression. Ia induction required a functional myelopoietic system as indicated by the finding that the response to LPS was eliminated in irradiated (900 rads) mice and reinstated by reconstitution with bone marrow cells. Comparison of LPS-induced Ia expression in normal and LPS-primed mice revealed a faster secondary response to LPS. The memory response could be adoptively transferred to normal mice with nonadherent spleen cells prepared 60 days after LPS injection. Spleen cells prepared 5 days after LPS injection caused Ia induction in LPSnonresponder mice; such induction was not observed in irradiated (900 rads) recipients. The cell responsible for this phenomenon was identified as a Thy-1+, immunoglobulin-negative nonadherent cell. The biosynthesis and expression of Ia were not increased by direct exposure of macrophages to LPS in vitro. Small amounts of LPS inhibited Ia induction by gamma interferon. LPS showed positive regulatory effects on Ia expression by delaying the loss of Ia expression on cultured macrophages and by stimulating the production of Ia-inducing factors. Supernatants from cultured spleen cells stimulated with LPS in vitro contained antiviral and Ia-inducing activity that was acid labile, indicating that the active factor is gamma interferon. We conclude that induction of Ia expression by LPS in vivo is a bone-marrow-dependent, radiation-sensitive process which involves the stimulation of a gamma interferon-producing accessory lymphocyte and a delay in Ia turnover.
Lipopolysaccharide (LPS) is an integral component of the outer membrane of gram-negative bacteria and has extremely potent biological activity (17, 18) . Our laboratory and others have shown that intraperitoneal (i.p.) injection of nanogram amounts of LPS results in a profound increase in peritoneal macrophage Ia expression (1, 32) . In keeping with the augmented Ia expression, LPS-elicited macrophages were more effective than normal macrophages in presenting antigen to T lymphocytes (32) .
When compared with other studies of Ia induction by gram-positive bacteria or adjuvants, the induction by LPS has several unique features. First, LPS is classically known as a T-cell-independent antigen (18) . The LPS-mediated elaboration of lymphokines, usually associated with T-cell activation, has not been easily detected or well studied. Also, la induction by LPS can occur in athymic nude mice (1, 31). Second, LPS is a well-defined structure with the lipid portion having potent biological activities. As such, Ia induction in response to lipid A may involve a novel mechanism. Third, the cellular response to LPS is under lps gene control (32) , which presents other questions and experimental avenues not relevant to other Ia-inducing agents. Fourth, the modulation of Ia by LPS occurs by distinctive kinetics: Ia expression is reduced early (3 days) after injection, but is augmented 7 to 14 days after injection (32) . Thus, both negative and positive regulatory effects require integration into a complete mechanistic picture. Finally, recent evidence indicates that LPS is the major, if not only, Ia- inducing agent active in the infectious disease process with viable pathogenic gram-negative bacteria (16) . While the relationship between Ia induction and protective immune responses remains to be well defined, it is likely that regulation of Ia plays a key role in the lymphocyte responses required for the resolution of infection and establishment of protective immunity. For these reasons, a thorough understanding of the events involved in LPS-mediated la regulation is warranted.
In the present study, we have used a combination of approaches, both in vivo and in vitro, to address stem cell requirements, LPS-reactive accessory cell involvement, the production of Ia-inducing factor, and the direct effects of LPS on macrophage Ia expression. A model to account for the demonstrated LPS-mediated events is discussed.
MATERIALS AND METHODS
Much of the methodology used in this study was identical to that described previously. Beginning several days prior to experimental manipulation. the mice were continuously treated with 1 g of tetracycline hydrochloride per liter dissolved in their drinking water.
LPS. The LPS utilized in these experiments was prepared from Salmonella minintesota R595 as described by Galanos et al. (9) . LPS was generously supplied by David (15, 32) .
IF was performed as stated previously (32) by plating PECs (with latex beads) on glass cover slips in 16- (24) . Following culture, macrophages were fixed and Ia expression was measured.
Reagents for in vitro experiments. ConA supernatant was generated as described previously (26) . These preparations, containing 85 to 1,400 U of gamma interferon (IFN-y) per ml, were termed lymphokine. Indomethacin (Sigma Chemical Co., St. Louis, Mo.) was diluted to a concentration of 10 mg/ml in 95% ethanol, stored at -20°C, and used at a final concentration of S pLg/ml in culture media. Recombinant IFN-y (rat) was purchased from Amgen Biologicals, Thousand Oaks, Calif. The interferon was reconstituted with sterile distilled water (106 U/ml), aliquoted, and stored at -700C.
Assay for antiviral activity. Antiviral activity was measured by LEE BioMolecular Research Laboratories, Inc., San Diego, Calif., using L929 murine fibroblasts challenged with encephalomyocarditis virus by the technique of Havell and Vilcek (11) . Results were normalized to a National Institutes of Health murine interferon reference reagent (G-002-904-511) and expressed as international reference units per milliliter. Acid lability of antiviral and Ia-inducing activity was tested by acidifying the supernatants (pH 2, overnight, 4°C) and then neutralizing to pH 7 prior to testing. RESULTS FACS analysis of Ia induction by LPS. The expression of IA by normal and LPS-elicited PECs was studied by using flow cytometry (Fig. 1) . PECs contained a population of larger (upper quadrants) and smaller (lower quadrants) cells corresponding to macrophages and lymphocytes, respectively. (Cells were identified as described in Materials and Methods and reference 32). In contrast to normal PECs, the PECs elicited by LPS showed a predominance of larger cells with increased fluorescent intensity; 43% of the PECs were in the upper right-hand quadrant. These results suggest that LPS causes a nearly complete shift in the IA expression of the peritoneal macrophage population. There was also a slight increase in staining of the smaller cell populations after LPS injection; the identity of such cells is not known.
Induction of IA by lipid A. LPS-mediated induction of Ia expression was due to the lipid A moiety. Figure 2 shows representative dose-response curves for the induction of IA and IE expression following injection of purified lipid A. The response to an optimum dose (1 Rg) of R595 LPS is also shown for comparative purposes. As little as 1 ng of lipid A caused significant Ia induction. In this and in other experiments not shown (32), the optimal induction by lipid A was always greater than that with LPS, and comparison of dose-response curves showed that the purified lipid A (1,797 molecular weight) was at least 10-fold more active (weight basis) than LPS (2,860 molecular weight). Thus, the Iainductive effect of R595 LPS is most likely due to the lipid A component.
Secondary responses to LPS. We compared la induction in response to both primary and secondary challenge with LPS.
An enhanced secondary response was observed 5 to 7 days following challenge injection (Fig. 3) . In isolated lipid A (Fig. 2) and the lack of responsiveness in LPS-nonresponder mice (32) indicate that the lipid A moiety is responsible for Ia induction. However, lipid A was 10-to 100-fold more active on a weight basis than R595 LPS, and this increased activity is greater than predicted by the lipid A content of the R595 LPS. It is possible, therefore, that the presence of some nonlipid component may have an inhibitory effect as reported previously (29) .
Several observations indicate that increased Ia is not due solely to a direct LPS interaction with peritoneal macrophages. These include (i) the radiation sensitivity and bone marrow reconstitution of the inductive event (Fig. 5); (ii) the secondary memory response to LPS and adoptive transfer of secondary responsiveness with nonadherent spleen cells (Fig. 3 : Tables 1 and 2 ); (iii) the ability to induce Ia in nonresponder mice with i.p. injections of LPS-activated nonadherent cells (Fig. 4 and Table 3 ): and (iv) the lack of Ia induction in vitro upon culture of isolated peritoneal macrophages with LPS (Fig. 6 ). It appears, therefore, that a more complex mechanism is operative.
The role of an intact myelopoietic system is suggested by Splenocytes were cultured for an additional 24 h in the presence of medium, 10 ,ug of R595 LPS per ml, or 2 pug of ConA per ml. Cell-free culture supernatants were then collected and tested (1:10 dilution) for IA-inducing capacity as described in Materials and Methods.
d Untreated and pH 2-treated (overnight, 4°C) factors were tested for antiviral activity on L929 murine fibroblasts challenged with encephalomyocarditis virus, using National Institutes of Health murine IFN as a standard.
IIA-inducing activity was determined by culturing peptone-elicited macrophages with the factors for 6 days (see Materials and Methods); then IA expression was determined by RIA. IA expression by macrophages cultured in medium alone was 136 + 40; in the presence of 10 ,ug of R595 LPS per ml, it was 141 ± 87.
generating Ia-inducing factors; and/or (iii) responsive to Ia-inducing factors. Because irradiated macrophages could respond in vitro to IFN-y with increased Ia (data not shown), the effects of irradiation cannot be explained by a direct effect on the response of mature macrophages in vitro. Furthermore, since Ia induction in response to transfer of LPS-activated spleen cells was also radiation sensitive (Fig.  4) but the Ia-inducing capacity of the transferred spleen cells was not affected by irradiation (data not shown), it is unlikely that the irradiation-induced inhibition is due only to the lack of development of cells which generate Ia-inducing factors. Thus, the most likely target for the effects of irradiation is the myelopoietic system involved in the genesis of cells responsive to Ia-inducing factors or to the direct effects of LPS or to both.
An accessory lymphocytelike cell contributes to Ta induction in response to LPS. The first indication for such a cell was the secondary response to LPS that exhibited rapidity, memory, and specificity ( Fig. 3 Table 3 ). The identification of the LPSreactive cell as a typical T lymphocyte would be compatible with reports that LPS can affect T-lymphocyte activation (4, 14, 28) . However, other observations appear to be inconsistent with this conclusion. We (31) (Fig. 6 ) and (ii) inhibited induction caused by lymphokine preparations and IFN-y (Fig. 6) .
LPS also slowed the decay of Ta expression usually observed upon culture of macrophages in the absence of inducing agents (Fig. 6) LPS was also involved in the production of Ia-inducing factors. Two conditions consistently resulted in Ia-inducing activity: (i) the culture of LPS-activated spleen cells in medium alone, and (ii) the addition of LPS to normal spleen cells after a 48-h preincubation in vitro ( Table 4 ). The factor generated by the second condition was identified as IFN--y by antiviral activity and pH 2 sensitivity; however, the factor elaborated under the first condition contained no detectable antiviral activity.
The most likely explanation for Ta induction without antiviral effects is that the antiviral assay is less sensitive than the Ia induction assay. The sensitivity of the antiviral assay is in the range of 2 to 5 U/ml, while <0. study using neutralizing antibodies to individual lymphokines will be required to address these issues properly.
The detection of antiviral effects without Ta-inducing activity (Table 4 ) is most likely due to the fact that LPS inhibits the Ta-inducing activity, but not the antiviral effects, of IFN-y (Fig. 6) . Thus, the presence of LPS in the factor preparations can mask the presence of IFN--y when Ia induction is measured.
Our working hypothesis for the mechanism of LPS-mediated induction of macrophage Ta expression involves the events depicted in Fig. 8 . An Ta-inducing factor elaborated by a lymphocytelike accessory cell(s) drives the production of Ia' macrophages from la-macrophages and bone marrow precursors. This pathway may be T-cell dependent or T-cell independent, as indicated by induction in athymic nude mice (31) . Whether the stimulation of an accessory cell is direct through membrane-receptor interaction or indirect by the elaboration of other immunoregulatory molecules (5) is an issue which we did not address. LPS also contributes to increased Ta by priming macrophages to respond to Tainducing factors and by inhibiting the conversion of Ta' to Ia-macrophages. These effects may occur simultaneously and result in the accumulation of Ia-expressing macrophages at the site of an LPS-mediated inflammatory response. Our results may be interpreted in the context of the initial decrease and then subsequent increase in Ta after injection of LPS i.p. (32) . The initial decrease may reflect the inhibitory effect of LPS on background levels of Ta expression regulated by a basal production of lymphokines. As the concentration of LPS decreases and Ta-inducing factor(s) increases, induction of Ta predominates. As such, Ta levels represent a critical balance between the inhibitory and stimulatory effects of LPS.
